Trade

with

ProPhase Labs Inc
(NASDAQ: PRPH)
AdChoices
1.42
+0.07
+5.19%
After Hours :
-
-
-

Open

1.50

Previous Close

1.35

Volume (Avg)

4.55k (25.43k)

Day's Range

1.33-1.50

52Wk Range

1.21-2.98

Market Cap.

27.40M

Dividend Rate ( Yield )

-

Beta

1.27

Shares Outstanding

19.30M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 25.03M

    • Net Income

    • 405.00k

    • Market Cap.

    • 27.40M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -8.96

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.27

    • Forward P/E

    • -

    • Price/Sales

    • 1.01

    • Price/Book Value

    • 2.01

    • Price/Cash flow

    • -15.58

      • EBITDA

      • 661.00k

      • Return on Capital %

      • -12.11

      • Return on Equity %

      • -17.64

      • Return on Assets %

      • -12.11

      • Book Value/Share

      • 0.71

      • Shares Outstanding

      • 19.30M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -7.30

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -

          • 7.80

          • Net Income

            Q/Q (last year)

          • -

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • 4.07

          • 6.10

          • Net Income

            5-Year Annual Average

          • -

          • 3.73

          • Dividends

            5-Year Annual Average

          • -

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 64.53

            • 69.92

            • Pre-Tax Margin

            • -8.96

            • 21.84

            • Net Profit Margin

            • -8.96

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 62.80

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -12.60

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • -12.50

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.32

              • Current Ratio

              • 2.30

              • 1.92

              • Quick Ratio

              • 1.63

              • 1.31

              • Interest Coverage

              • -174.67

              • 17.64

              • Leverage Ratio

              • 1.45

              • 2.03

              • Book Value/Share

              • 0.71

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -10.36

                • 21.88

                • P/E Ratio 5-Year High

                • -23.03

                • 193.96

                • P/E Ratio 5-Year Low

                • -3.79

                • 87.26

                • Price/Sales Ratio

                • 0.95

                • 3.70

                • Price/Book Value

                • 1.90

                • 3.69

                • Price/Cash Flow Ratio

                • -15.58

                • 13.85

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -17.64

                        (-15.60)

                      • 17.42

                        (18.66)

                      • Return on Assets %

                        (5-Year Average)

                      • -12.11

                        (-10.30)

                      • 8.45

                        (8.77)

                      • Return on Capital %

                        (5-Year Average)

                      • -17.54

                        (-15.60)

                      • 12.41

                        (13.18)

                      • Income/Employee

                      • -

                      • 90.07k

                      • Inventory Turnover

                      • 2.55

                      • 2.46

                      • Asset Turnover

                      • 1.35

                      • 0.46

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      416.00k
                      Operating Margin
                      1.66
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -15.58
                      Ownership

                      Institutional Ownership

                      15.26%

                      Top 10 Institutions

                      15.22%

                      Mutual Fund Ownership

                      1.40%

                      Float

                      73.88%

                      5% / Insider Ownership

                      36.10%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Extended Market Index Fund

                      •  

                        72,896

                      • 0.00

                      • 0.38

                      • DFA U.S. Micro Cap Portfolio

                      •  

                        56,585

                      • 0.00

                      • 0.29

                      • Vanguard Total Stock Mkt Idx

                      •  

                        56,433

                      • 0.00

                      • 0.29

                      • DFA Tax Managed U.S. Small Cap Portfolio

                      •  

                        28,021

                      • 0.00

                      • 0.15

                      • DFA U.S. Core Equity II Fund

                      •  

                        19,981

                      • 0.00

                      • 0.10

                      • DFA U.S. Small Cap Portfolio

                      •  

                        15,982

                      • 0.00

                      • 0.08

                      • DFA U.S. Vector Equity Fund

                      •  

                        6,052

                      • 0.00

                      • 0.03

                      • DFA US Core Equity I Fund

                      •  

                        3,827

                      • 0.00

                      • 0.02

                      • Dimensional US Sm Company

                      •  

                        3,100

                      • 0.00

                      • 0.02

                      • DFA T.A. U.S. Core Equity 2 Portfolio

                      •  

                        2,300

                      • 0.00

                      • 0.01

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • BML Investment Partners LP

                      •  

                        1,773,060

                      • +83.36%

                      • 9.19

                      • Vantage Investment

                      •  

                        437,915

                      • 0.00%

                      • 2.27

                      • BNY Mellon Wealth Management

                      •  

                        234,000

                      • 0.00%

                      • 1.21

                      • Dimensional Fund Advisors, Inc.

                      •  

                        188,979

                      • -2.07%

                      • 0.98

                      • Vanguard Group, Inc.

                      •  

                        129,294

                      • +4.27%

                      • 0.67

                      • Pnc Bank, National Association

                      •  

                        60,000

                      • 0.00%

                      • 0.31

                      • California Public Employees Retrmnt Sys

                      •  

                        47,401

                      • 0.00%

                      • 0.25

                      • Renaissance Technologies Corp

                      •  

                        35,600

                      • -24.54%

                      • 0.18

                      • Commonwealth Equity Services Inc

                      •  

                        19,305

                      • 0.00%

                      • 0.10

                      • Northern Trust Investments, N.A.

                      •  

                        11,590

                      • 0.00%

                      • 0.06

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Major

                      Type

                      Speculative Growth

                      Style

                      Small Core

                      ProPhase Labs Inc is organized in Nevada in July 1989. The Company manufactures, markets and distributes homeopathic and health products that are offered to the general public. It also is engaged in the research and development of po...moretential over-the-counter drug, natural base health products along with supplements, personal care and cosmeceutical products. It manufactures, distributes and markets over-the-counter cold remedy products to consumers through national chain, regional, specialty and local retail stores. Its flagship brand is Cold-EEZE Cold Remedy and its product is Cold-EEZE zinc gluconate lozenges, proven in clinical studies to reduce the duration and severity of symptoms of the common cold by 42%. In addition to Cold-EEZE Cold Remedy lozenges, the Company markets and distributes non-loz...moreenge forms of zinc gluconate formulations: Cold-EEZE Cold Remedy QuickMelts and Cold-EEZE Cold Remedy Oral Spray. The Company expanded its Cold-EEZE Cold Remedy QuickMelts product line and shipped two products: Cold-EEZE Plus Immune Support QuickMelts and Cold-EEZE Plus Immune Support + Energy QuickMelts to retailers in July 2013. The company acquired manufacturing and distribution rights to its lozenge formulation in 1992 and commenced national marketing in 1996. The Company maintains trademarks for its products including Cold-EEZE, Kinds-EEZE, QuickMelts, Organix Rx Complete and Organix Rx Defense. The company is subject to federal and state laws and regulations adopted for the health and safety of users of pharmaceutical and health care products.lessless

                      Key People

                      Ted Karkus

                      Director/Chairman of the Board/CEO

                      Robert V. Cuddihy,Jr

                      CFO/COO/Executive VP

                      Mr. James T. McCubbin

                      Director

                      Dr. Louis Gleckel,M.D.

                      Director

                      Mark Burnett

                      Director

                      • ProPhase Labs Inc

                      • 621 North Shady Retreat Road

                      • Doylestown, PA 18901

                      • USA.Map

                      • Phone: +1 215 345-0919

                      • Fax: -

                      • prophaselabs.com

                      Incorporated

                      1989

                      Employees

                      50

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: